Stockreport

Stronger 2025 Outlook And Fragile X Trial Start Might Change The Case For Investing In Mirum (MIRM) [Yahoo! Finance]

Mirum Pharmaceuticals, Inc. - common stock  (MIRM) 
Last mirum pharmaceuticals, inc. - common stock earnings: 3/12 04:02 pm Check Earnings Report
PDF Mirum Pharmaceuticals recently reported better-than-expected third-quarter 2025 earnings and revenue, raised its full-year 2025 revenue guidance to US$500 million–US$510 [Read more]